U.K. UTI drug switch
This article was originally published in The Tan Sheet
Executive Summary
The Medicines and Healthcare Products Regulatory Agency announces June 21 it seeks comments on moving an antibiotic for recurrent urinary tract infections in women from prescription only medicine to pharmacy status. MHRA seeks comments on moving azithromycin 500 mg, Pfizer's Zithromax, to pharmacy status. Comments are due by Aug. 2. In 2005, MHRA said azithromycin could be a switch candidate (1"The Tan Sheet" June 6, 2005, p. 4)...